Oncotarget

Research Papers:

T-cell responses to KSHV infection: a systematic approach

Romin Roshan, Nazzarena Labo, Matthew Trivett, Wendell Miley, Vickie Marshall, Lori Coren, Elena M. Cornejo Castro, Hannah Perez, Benjamin Holdridge, Eliza Davis, Rodrigo Matus-Nicodemos, Victor I. Ayala, Raymond Sowder II, Kathleen M. Wyvill, Karen Aleman, Christine Fennessey, Jeffrey Lifson, Mark N. Polizzotto, Daniel Douek, Brandon Keele, Thomas S. Uldrick, Robert Yarchoan, Claes Ohlen, David Ott and Denise Whitby _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:109402-109416. https://doi.org/10.18632/oncotarget.22683

Metrics: PDF 1560 views  |   HTML 4339 views  |   ?  


Abstract

Romin Roshan1, Nazzarena Labo1, Matthew Trivett1, Wendell Miley1, Vickie Marshall1, Lori Coren1, Elena M. Cornejo Castro1, Hannah Perez1, Benjamin Holdridge1, Eliza Davis1, Rodrigo Matus-Nicodemos2, Victor I. Ayala1, Raymond Sowder II1, Kathleen M. Wyvill3, Karen Aleman3, Christine Fennessey1, Jeffrey Lifson1, Mark N. Polizzotto3, Daniel Douek2, Brandon Keele1, Thomas S. Uldrick3, Robert Yarchoan3, Claes Ohlen1, David Ott1 and Denise Whitby1

1AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA

2Vaccine Research Center, National Institute of Allergy and Infectious Disease, Bethesda, MD, USA

3HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, USA

Correspondence to:

Denise Whitby, email: [email protected]

Keywords: KSHV; ELISpot; T-cells; cell-mediated immunity

Received: August 25, 2017     Accepted: November 05, 2017     Published: November 25, 2017

ABSTRACT

Prior studies of T-cell responses to KSHV have included relatively few participants and focused on relatively few KSHV antigens. To provide a more comprehensive analysis, we investigated T-cell responses to the whole KSHV proteome using IFN-γ ELISpot. Using ~7,500 overlapping 15mer peptides we generated one to three peptide pools for each of the 82 KSHV ORFs. IFN-γ ELISpot analysis of PBMCs from 19 patients with a history of KSHV-associated disease and 24 healthy donors (11 KSHV seropositive) detected widely varied responses. Fifty six of the 82 ORFs were recognized by at least one individual but there was little overlap between participants. Responses to at least one ORF pool were observed in all 19 patients and in 7 seropositive donors. Four seropositive donors and 10 seronegative donors had no detectable responses while 3 seronegative donors had weak responses to one ORF. Patients recognised more ORFs than the donors (p=0.04) but the response intensity (spot forming units: SFU per million cells) was similar in the two groups. In four of the responding donors, individual peptides eliciting the predominant responses were identified: three donors responded to only one peptide per ORF, while one recognized five. Using intracellular cytokine staining in four participant samples, we detected peptide-induced IFN-γ, MIP1-β, and TNF-α as well as CD107a degranulation, consistent with multifunctional effector responses in CD8+ and CD4+ T cells. Sequence analysis of TCRs present in peptide specific T-cell clones generated from two participants showed both mono- and multi-clonotypic responses. Finally, we molecularly cloned the KSHV specific TCRs and incorporated the sequences into retroviral vectors to transfer the specificities to fresh donor cells for additional studies. This study suggests that KSHV infected individuals respond to diverse KSHV antigens, consistent with a lack of shared immunodominance and establishes useful tools to facilitate KSHV immunology studies.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22683